Agentic AI Systems for Drug Discovery and Business Intelligence
loka · Tech · 2025 · source Agentic: yes · promotional bias: med · source-backed · extracted with prompt 0.5.2 (schema v2)
Generated from extraction.json — do not edit by hand. Every claim cites verbatim source evidence; stated means the quote directly asserts the claim, implied means it supports it indirectly.
Problem
Domain: Drug discovery and business intelligence
Loka and Domo presented agentic AI systems that move beyond chatbots into assistants for drug discovery, call centers, and financial analysis.
Constraints:
- Multiple data sources
- Human oversight
- Production readiness
- Industry-specific workflows
Architecture
The Loka/Domo discussion shows two agentic production patterns. Loka's ADA drug-discovery assistant uses a backend agent to query pathway databases, STRING DB, GEO, UniProt, protein-folding models such as ESMFold, docking models such as DiffDock, and visualizers from natural-language prompts. Domo's platform exposes data sources, agent tasks, tools, human-in-the-loop steps, and Bedrock-backed safeguards for BI and call-center workflows. Both emphasize model agnosticism, routing, security boundaries, and production readiness over one chatbot endpoint.
Diagram confidence: reconstructed (reconstructed from prose).
flowchart LR drug-discovery-prompt[Drug discovery prompt] --> ada-backend-agent[ADA backend agent] ada-backend-agent --> scientific-databases[Scientific databases] ada-backend-agent --> predictive-model-tools[Predictive model tools] ada-backend-agent --> visualization-outputs[Visualization outputs] domo-agent-platform[Domo agent platform] --> business-data-sources[Business data sources] domo-agent-platform --> human-review[Human review]
Components
| Component | Role | Interacts with |
|---|---|---|
Drug discovery prompt |
Natural-language research request for pathways, proteins, genes, structures, or molecules. | ADA backend agent |
ADA backend agent |
Agent that selects databases, predictive models, and output generation steps. | Drug discovery prompt, Scientific databases, Predictive model tools, Visualization outputs |
Scientific databases |
KEGG, STRING DB, GEO, UniProt, and other internal/external sources. | ADA backend agent |
Predictive model tools |
Protein folding and docking models such as ESMFold and DiffDock. | ADA backend agent |
Visualization outputs |
CSV downloads and 3D visualizers for structures and docking outputs. | ADA backend agent |
Domo agent platform |
BI platform for data-source-connected agentic workflows. | Business data sources, Human review |
Business data sources |
Customer databases, data lakes, and SaaS data exposed to Domo agents. | Domo agent platform |
Human review |
Human-in-the-loop path for sensitive business decisions and customer-facing workflows. | Domo agent platform |
Data flow
In ADA, a researcher asks a drug-discovery question; the backend agent queries pathway, protein-interaction, expression, sequence, folding, docking, and visualization resources; outputs are summarized, downloaded, or rendered. In Domo, business data sources and agent tasks feed agentic workflows, with human review available before sensitive actions or customer-facing changes.
3 supporting quotes
Why this architecture
The presenters argue that production agent systems need routing, model agnosticism, security, governance, and data readiness. ADA decomposes drug discovery into database/model calls because researchers otherwise switch between fragmented tools, while Domo emphasizes agents over governed business data with humans in the loop for higher-risk actions.
3 supporting quotes
Models used: ESMFold · DiffDock · LLMs · Bedrock-hosted models
Scale
- Loka reports that the majority of the referenced customer work moved to production.“Uh the majority of those have actually moved to production. So have stories of these things working actually in the wild outside of proof of concepts.”transcript, stated
Alternatives considered (roads not taken)
Single expensive model for every request
Rejected because: Production systems need model routing for nonsensical, simple, and complex requests.
Assume generative models can use any data as-is
Rejected because: The panel warns that unstructured tolerance does not remove data-readiness requirements.
Patterns
multi-agent-orchestration (cross-industry)
The presenters describe moving beyond chatbot/RAG into multi-agent systems over complex data.
human-in-the-loop-gate (oversight)
The systems maintain human oversight while allowing agents to take actions.
Tradeoffs
Design for model agnosticism and routing.
Chose Shared infrastructure that can route nonsensical, simple, and complex requests to different model paths over Sending every request to the most expensive model.
Rationale: Production agentic systems needed cost control, scale, and the ability to combine specialized models for different subtasks.
How to control production inference cost.
Chose model routing and model agnosticism over one frontier model for every path.
Rationale: Different requests warrant different model costs and capabilities in production.
Gotchas (what bit them)
Generative AI still depends on mature, secure, and accessible data.
Root cause: Unstructured-data tolerance does not make poor, inaccessible, or insecure data usable in production.
Resolution: Loka evaluates data readiness, security boundaries, governance, and baseline performance early in the discovery period.
Evaluation
The transcript gives production examples but does not provide a consistent metric framework.
Outcomes
- The examples had moved to production according to the transcript.
The summary characterizes them as production implementations across industries.